Chronic Stable Angina and Coronary Artery Disease (CAD)
Definition of Chronic Stable Angina: This is chest pain caused by the heart muscle demanding more oxygen than it is currently receiving, typically occurring under physical or emotional stress.
Duration: The pain usually lasts less than 15minutes.
Relieving Factors:
Rest and relaxation (stopping the activity that increased demand).
Nitroglycerin administration.
Mechanism of Nitroglycerin: It is a vasodilator that widens the coronary arteries to increase blood flow and oxygen delivery to the myocardium.
Risk Factors for Coronary Artery Disease
Non-modifiable Risk Factors (Unchangeable):
Age: Risk increases as individuals get older.
Sex: More common in men until approximately age 70 to 75, at which point the risk levels out or flips.
Family History/Genetics: Having a first-degree relative (mother, father, sibling) with CAD significantly increases personal risk.
Race and Ethnicity: More common in white individuals; however, Black or African American individuals have a higher mortality rate due to the disease.
Modifiable Risk Factors (Changeable/Improvable):
Physical Inactivity: Sedentary lifestyles (e.g., sitting at a desk job followed by sitting on the couch).
Diet: High-fat, high-salt diets and highly processed foods.
Obesity: Often a result of poor diet and inactivity.
Tobacco Smoke: Includes cigarette smoking and vaping.
Comorbidities: High blood pressure (hypertension), high cholesterol, and diabetes.
Clinical Presentation and Signs of Angina
Asymptomatic Phase: Plaque buildup often begins in the teens or twenties (especially due to the American diet and activity levels), but patients may remain asymptomatic for years.
Symptoms of Angina:
Chest pain described as pressure, fullness, or a squeezing sensation.
Substernal Pain: Pain located in the middle of the chest.
Radiation Patterns:
Radiation to the left arm or the jaw.
Female Specifics: Women are more likely to experience indigestion, nausea, vomiting, and pain radiating between the scapulae (back pain) rather than frontal chest pain, partly due to breast tissue.
Associated Symptoms: Diaphoresis (sweating), shortness of breath, shakiness, dizziness, and coolness/clamminess.
Extreme Temperatures: Shock to the system from very cold or very hot weather.
Other Triggers: Smoking tobacco (causes vasoconstriction) and stimulants (e.g., methamphetamine, cocaine), which increase heart rate and oxygen demand.
Acute Coronary Syndrome (ACS)
General Characteristics: Characterized by unrelieved chest pain lasting longer than 15minutes. It represents a move toward a more unstable patient status.
Types of ACS:
Unstable Angina: Narrowing of the artery where blood flow is decreased but some still passes through. There is no necrosis (tissue death) yet.
Non-STEMI (Non-ST Elevation Myocardial Infarction): More severe occlusion than unstable angina (e.g., three-fourths or more). Barely any blood flow reaches the heart, leading to localized ischemia and potential necrosis.
STEMI (ST Elevation Myocardial Infarction): Complete occlusion of the coronary artery. No blood flow or oxygen reaches the area, resulting in ischemia and necrosis of a larger region of heart muscle.
Comparative ACS EKG Changes and Management
Unstable Angina:
EKG Change: T-wave inversion (described as going down instead of up).
Analogy: The "smiley face" (though medically concerning, it means some blood is still reaching the heart).
Non-STEMI:
EKG Change: ST segment depression (the "s" part of the QRS complex is down).
Timeframe: Not as emergent as STEMI; treatment (cardiac cath) is usually required within 12 to 24hours.
Thrombolytic Therapy: Not used for NSTEMI because the clot is not completely occluding the artery and the risk of bleeding outweighs the benefit.
STEMI:
EKG Change: ST elevation. The "s" part of the QRS flows upward into the T-wave.
Analogy: The "frowny face" (highly concerning due to complete occlusion).
Timeframe: Emergent medical priority. The goal is to reach the cath lab within 60 to 90minutes of arrival at the emergency department.
Intervention: Cardiac catheterization/PCI or thrombolytic therapy (clot busters like TPA).
Cardiac Biomarkers (Laboratory Tests)
Troponin: The gold standard and most specific marker for cardiac tissue damage.
Elevation: Starts within 4hours of damage and stays elevated for up to 10days.
Serial Monitoring: Usually drawn every 4hours to trend values.
Normal Values: Troponin T is typically less than 0.1ng/mL; Troponin I is typically less than 0.03ng/mL.
CK-MB (Creatine Kinase-Muscle Brain): Specific to heart muscle.
Elevation: Detectable within 4hours, but only stays elevated for approximately 3days.
Myoglobin: Earliest marker to rise.
Elevation: Rises within 1hour of damage but returns to normal within 24hours (low specificity).
Lipid Panel: Cholesterol levels are drawn to assess risk factors and long-term plaque stabilization needs.
Immediate Interventions for ACS (The MONA Protocol)
First Action: Obtain a 12-lead EKG immediately when a patient reports chest pain.
MORHINE (M): Administered IV to help with pain and increase perfusion.
OXYGEN (O): Typically started at 2liters to increase oxygen delivery to the myocardium.
NITRATES (N): Nitroglycerin to dilate coronary arteries.
ASPIRIN (A): A large dose of 325mg (not a low-dose / "baby" aspirin) is chewed or swallowed to prevent further platelet aggregation.
Pharmacological Maintenance and Treatment
Anti-hyperlipidemics (Statins):
Examples: Atorvastatin, Lovastatin.
Goal: Lower LDL (bad cholesterol), raise HDL (good cholesterol), and stabilize existing plaque.
Side Effects: Liver damage (monitor LFTs: AST and ALT) and Rhabdomyolysis (monitor for myopathy/muscle pain and dark urine).
Nitrates:
Short-acting: Sublingual tablets for acute pain (1 tablet every 5minutes for up to 3 doses; call 911 after the second dose if at home).
Long-acting: Taken daily to keep arteries dilated.
Side Effects: Headache (expected, treat with Acetaminophen) and Hypotension (change positions slowly).
Storage: Keep in original brown tinted glass containers to protect from light.
Beta Blockers:
Examples: Metoprolol, Atenolol.
Action: Decreases oxygen demand and heart rate.
Nursing Priority: Hold if heart rate (HR) is less than 60bpm. Be cautious in asthmatics (risk of bronchospasm).
ACE Inhibitors:
Examples: Lisinopril, Captopril.
Side Effects: Dry cough (report but not emergency), Hyperkalemia, and the most severe: Angioedema (swelling of lips/tongue is an airway priority).
Calcium Channel Blockers:
Examples: Nifedipine, Diltiazem.
Side Effects: Peripheral edema (swollen ankles) and hypotension.
Antiplatelets:
Examples: Aspirin, Clopidogrel (Plavix).
Purpose: Essential after stent placement (dual antiplatelet therapy for up to a year) to prevent clots in the mesh stent.
Thrombolytics/Anticoagulants:
TPA: Used only for STEMI to break down existing clots.
Heparin/Enoxaparin: Prevent existing clots from enlarging; used during cath procedures. Monitor PTT, INR, and Platelets (watch for Heparin-Induced Thrombocytopenia).
Steps for Cardiac Catheterization and PCI
Purpose: To visualize arteries using dye and potentially insert a stent via a balloon (Percutaneous Coronary Intervention).
Pre-procedure Care:
Verify signed consent.
Check for allergies to contrast dye or shellfish.
Check renal function: GFR, Creatinine, and BUN (dye is nephrotoxic).
Hold Metformin for 48hours before a scheduled procedure to prevent lactic acidosis.
Post-procedure Care:
Maintain the insertion site extremity (brachial or femoral) straight and flat for 4 to 6hours.
Perform a neurovascular assessment (the "5 Ps"): Pulse (must be 2+), Capillary Refill (<3seconds), Temperature (warm), Color (normal), and Sensation.
Hydrate the patient to flush out contrast dye.
Monitor for bleeding or hematoma at the site.
No heavy lifting (greater than 10lbs) or straining (bowel movements) for several days.